{"id":"W2303984794","doi":"10.1200/jco.2010.28.15_suppl.tps189","title":"PEAK: A randomized phase II study to compare the efficacy of panitumumab plus mFOLFOX6 to bevacizumab plus mFOLFOX6 in patients (pts) with previously untreated, unresectable metastatic colorectal cancer (mCRC) expressing wild-type <i>KRAS</i>.","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Panitumumab; Bevacizumab; Medicine; KRAS; Colorectal cancer; Internal medicine; Oncology; Cetuximab; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Phases of clinical research; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001452648,0.002110686,0.002133487,0.0005378341,0.0003938028,0.001217877,0.001243564,0.001291041,0.01043906],"category_scores_gemma":[0.001347987,0.0008164906,0.00141216,0.0004957814,0.00117247,0.001591611,0.0006029161,0.00285046,0.001514943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001189966,"about_ca_system_score_gemma":0.002235849,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001138702,"about_ca_topic_score_gemma":0.002341582,"domain_scores_codex":[0.9995797,0.0002020948,0.00001868728,0.00007653254,0.00003092917,0.00009196517],"domain_scores_gemma":[0.9991564,0.0001770359,0.0001790032,0.00005089979,0.000043954,0.0003927495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9758212,0.008876791,0.0005864166,0.0002342163,0.0003606281,0.00003921804,0.00002584899,0.0003723016,0.002382081,0.00007478398,0.000827728,0.01039879],"study_design_scores_gemma":[0.8971188,0.1002755,0.001165312,0.00001225927,0.0002378034,0.00003380871,0.00001397876,0.0003099305,0.0003277786,0.0001044769,0.0003922506,0.000008021127],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835579,0.001855387,0.001247426,0.000753765,0.0003674106,0.006386054,0.002443572,0.000364764,0.003023637],"genre_scores_gemma":[0.9771904,0.001587416,0.003021014,0.001606068,0.0005009824,0.008524144,0.003463608,0.00006359559,0.004042667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01043906,"threshold_uncertainty_score":0.03492218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07185874467844428,"score_gpt":0.4433127540103353,"score_spread":0.371454009331891,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}